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A series of nowl cbromone/aza-chromone fused u-aminophosphonate derivatives were synthesized in good yields using 
silica chloride as the catalyst. All the synthesized compounds were tested for their c-Src kinase inhibitory activity. Aza .. 
chromone compound showed Src kinase inhibition with an ICso value of 15.8 µM. The compounds were subjected to 
molecular docking and dynamics simulations to study the atomic level interactions with an unphosphorylated proto-
oncogenic tyrosine protein kinase Src (PDB code 1 Y57) as well as phosphorylated tyrosine protein kinase Src (PDB code 
2H8H). Docking and molecular dynamic results revealed phosphorylated Src tyrosine kinase protein better results than 
unphosphorylated tyrosine Src kinase protein. Chemoinformatics study revealed the compounds had lead like properties. 
Machine learning (SVR) models were built to study the structure activity correlations. A CC of 0.835 was obtained when the 
SVR model was applied to the 17 synthesized compounds. It is envisaged that the work will provide guidelines for future 
drug design efforts for Src kinase inhibitors. 
Keywords: Phosphorylated cSrc kinase, Cromone Com.pounds, Correlations, Tyrosine Kinase Protein, Proto-Oncogenic 
Introduction 
Src tyrosine kinase overexpression is regularly 
implicated in number of cancer diseases, such as 
colon, lung, breast, prostate, ovary and pancreas1• 
There has been raising interest in the development of 
Src kinase inhibitors in recent years, both for their use 
as research probes, delineating the specific functions 
of these kinases, and as potential anticancer/related 
therapeutics. Chromone is well recognized as a 
privileged motif, due to its abundance in various 
natural products with wide range of biological 
properties that include anti-bacterial, antifungal, anti-
cancer, anti-HIV and anti-ulcer agents2•3• Similarly, a.-
aminophosphonates and a-amino phosphonicacids 
constitute an important group of naturally occurring 
compounds that are considered as isoelectronic 
analogues of the natural a-amino acids. Recently, 
coumarin and chromone derivatives have also been 
evaluated for their Src kinase inhibition4 . However, 
chromone/azachrom.one fused a-aminophosphonate 
*Author for Correspondence 
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conjugates have not been studied as Src kinase 
inhibitors. In this context, and in view of our 
long-standing interest in the chemistry of privileged 
chromone motif for various biological applications5, 
in the present study, we report the synthesis of 
chromone/azachromone fused a-amino phosphonate 
conjugates. This study also provides insights on 
the structure activity relationship as well as the Src 
kinase interaction with these compounds using 
molecular modeling and molecular dynamics simulation 
studies. 
Methodology 
Synthesis 
Synthesis of the targeted compounds is shown 
in Figure 1. Commercially available 2-hydroxy .. 
acetophenone/2- aminoacetophenone was subjected 
under Vilsmier condition as per the reported procedure 
to obtain the key intermediate 3 .. chromone carboxal-
dehyde/ 3- azacbromone carboxaldehyde. Further, 
these aldehydes on condensation with different 
amines and diethyl phosphite in presence of silica 
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silica chloride 
EtOH,60°C 
8·12h 
1a X•O 
1b X•NH 
41(85%,8h} 
'8t78%.10h) 
2 
6(00%.12h} 
4n (75%, 10 h) 
3 
~ 
4o(82%, 10h) ld(35%, 12h) .C.(10%.12h) 4f(S0%.10h) 
4i(18%.1Zh) 
Ao(72%. 12 h) 
.. (85%.Sh) 
Fig. 1 - Silica chloride- catalyzed one pot three component synthesis of a-aminophosphonates ( 4a-4q) 
chloride provided chromone/azachromone fused a-
aminophosphonates6'7. 
Most of the compounds were obtained in good 
yields with reaction time of 8-12 hours. It should be 
noted that when this three component reaction was 
performed in the absence of silica chloride, no 
product formation was observed. The structures of 
the compounds were confirmed by 1H NMR, 13C 
NMR and mass spectral analysis8• 
Biological evaluation 
Phosphate esters, carboxylic acids, and tetrahedral 
intermediates are present in the metabolic and 
signaling pathways. Phosphonates have the ability to 
structurally mimic the above organic compounds, thus 
serving as a small-molecule inhibitor of multiple 
processes9• Phosphonates are used as enzyme 
inhibitors, potent antifungal, herbicidal, antiparasitic, 
or antimicrobial agents. Glyphosate is the active 
ingredient in commercial herbicide and inhibits 5-
enolpyruvylshikimic acid 3-phosphate synthase 
(ESPS) which is critical in the biosynthesis of 
aromatic amino acids in plants10• All the synthesized 
compounds were screened for their Src kinase 
inhibitoiy activity. The minimum inhibitoiy concentration 
(MIC: µg/ mL) was determined for each compound. 
Most of the compounds failed to produce very good 
inhibition homomeric compounds 4c & 4o showed 
moderate activity with IC5o = 40.6 & 63.6 µg/ mL. 
One of the compound 4j showed good Src kinase 
inhibition with IC5o value of 15.8 µg/ mL. 
Cell culture assay and cell proliferation assay 
Kinases play a key role in a number of 
physiological processes and their inhibitors are seen 
to exhibit anticancer activity against various human 
cancer cell lines11• Kinase inhibition assays are widely 
used enzyme inhibition screening assays. Similarly 
binding constant assay and TR -FRET assay have seen 
to have potencies against both Src kinase. Human 
ovarian adenocarcinoma cell line SK-OV3 (ATCC no. 
HTB-77) and human colon adenocarcinoma HT-29 
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(ATCC no. HTB·38) were obtained from American 
Type Culture Collection. Cells were grown on 75 cm2 
cell culture flasks with EMEM (Eagle's minimum 
essential medium), supplemented with 10% fetal 
bovine serum, and 1 % penicillin/streptomycin 
solution ( 10,000 units of penicillin and 10 mg of 
streptomycin in 0.9% NaCl) in a humidified 
atmosphere of 5% C02, 95% air at 37 °C. Cell 
proliferation assay was carried out using CellTiter 
96 aqueous one solution cell proliferation assay kit 
(Promega, USA). 
Preparation of macromolecule 
The protein targets retrieved from RCSB Protein 
Data Bank were unphosphorylated proto .. oncogenic 
tyrosine protein kinase Src (PDB code 1Y57) 
and phosphorylated tyrosine protein kinase Src (PDB 
code 2H8H) which served as docking receptors. 
The proteins were fixed for errors in atomic 
representations and optimized using Protein Preparation 
Wizard Maestro vl0.3 12• The bond orders were 
assigned to residues, hydrogen atoms were added at 
pH 7.0. Minimization was carried out using OPLS 
2005 force field with a RMSD cutoff value of 0.3A. 
Preparation of ligands; The 20 structures of all 
compounds i.e. 4c, 4i, 4j, staurosporine and PP2 were 
drawn and analyzed by Marvin view. The compounds 
were converted to 3D structure ( .pdb) using LigPrep 
tool13• LigPrep is a Schr5dinger suite tool which is 
used to. generate 3D structures from 2D structures, 
search tautomers, isomers for compounds and carry 
out energy minimization by applying the OPLS 2005 
force field. 
Molecular docking 
The molecular docking was performed and 
analyzed via the Glide v6.8 docking tool 14• The 
receptor grid was centered based on the active site of 
the protein using receptor grid generation tool. 
Ligands prepared using LigPrep were flexibly docked 
in grid box using Monte Carlo based simulation 
algorithm. An extra precision (XP) method was 
employed that generated binding poses based on 
energy. The favourably docked molecules were 
ranked according ·to the Glide Score. 
Molecular dynamics simulation 
The docked c-Src kinase proteins with compound 
4j were subjected to molecular dynamics simulation 
with the CHARMM 36 force field in GROMACS 4.6 
tool 15• The simulation was minimized using 5000 
steps of Steepest Descent method. The system was 
later equilibrated at 300 Kelvin temperature and 1.06 
pressures for 200 ps. The time step set was 0.2 fs. The 
final production was run for 20ns and the distance, 
RMSF and hydrogen bond trajectories were 
calculated for the protein-ligand system. 
Structure activity correlation models 
The 2D descriptors and Principal components were 
computed in MOE CCG computing package. The 
SVR model was developed using the RapidMiner data 
mining program 16• The construction, validation of the 
SVR model was partitioned into three subsets in 
70:20: 10 ratio and the model was built by employing 
the s·S VR algorithm and radial basis function 
(RBF) kernel function, and validated using five-fold 
validation technique. The algorithm utilizes three 
parameters, viz. cost function (C), kernel gamma (y) 
and width of the loss function ( s ). 
Results and Discussion 
Synthesis 
Syntheses of the targeted a.-aminophosphonate 
derivatives ( 4a .. q) were prepared through a three 
component reaction involving aldehydes, amines and 
phosphites employing Kabachnik-Fields reaction 17 
condition. To the best of our knowledge, no previous 
reports using this catalyst for such reaction have been 
reported. All the synthesized compounds have been 
evaluated for their c-Src kinase inhibitory activity. 
The IC5o value (µM) was determined for each 
compound. Staurosporine and PP2 were employed as 
the positive controls. Out of the seventeen compounds 
screened, three compounds (4c, 4j, 4o) showed 
moderate Src kinase inhibition in the range of ICso 
values between 15.8--63.6 µM. In particular, 
compound 4j, was identified as the potent inhibitor 
(1Cs0=15.8 µM) in the series. 
Molecular docking analysis 
With an objective to explore the binding potential 
of the synthesized and tested molecules for Src 
tyrosine kinase, we performed docking studies as 
shown in Table 1. Among the 17 structures, 
compounds 4c, 4i and 4j were mainly investigated 
further for docking simulations since they exhibit 
higher inhibitory activity as ascertained from their 
MIC data. Human c-Src tyrosine kinase is a multi-
domain protein consisting of 535 amino acids 
possessing SH3, SH2 domains followed by a short 
N-terminal and C-terminal regulation segment18• In 
the unphosphorylated structure, the SH2 and SH3 
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Table 1 - Molecular docking analysis of phosphorylated and unphosphorylated c-Src kinase tyrosine protein with selected 
compounds. The binding energies were calculated using Glide v6.8 docking tool. - : No docking score was obtained 
Unphosphorylated Protein: 1 Y57 Phosphorylated Protein: 2H8H 
Sr. no Compound Amino acids involved in GLIDE Score Amino acids involved in GLIDE Score 
intermolecular interactions (kcal/mol) intermolecular interactions (kcal/mol) 
4c Lys295 -4.5 Lys295 -5.0 
Asp404 Ala390 
2 
3 
4 
5 
6 
7 
4i 
4j 
4p 
4m 
Staurosporine 
PP2 
Asp404 
Lys295 
Ala390 
Met341 
Met341 
domains lie at a right angle to each other, with only 
SH3 domain in contact with the N-terminal lobe19• 
The SH3 domain is bound between SH2 and kinase 
domains in this inactive conformation20• The C-
terminal tail folds back to N-terminal, and the active 
site is exposed as it is not blocked by the activation 
loop21 • Upon phosphorylation of Tyr527 in C-terminal 
or Tyr 416 in the activation loop, the SH2 and SH3 
domains lie parallel to the N and C lobes forming an 
open and closed cleft that determines the access to the 
catalytic site22• Phosphorylation of Tyr 527 down 
regulates the kinase activity and phosphorylation of 
Tyr 416 is deemed necessary for exhibiting full kinase 
activity. The binding site in c-Src protein is an ATP 
pocket present in the N-lobe region21 • Compound 4j 
and 4c were bound to the Lys295 residue present in 
the C-terminal region of the pocket that acts as an 
important site for catalysis, binding of a compound to 
the terminal inhibits further kinase activity. Docking 
against the un-phosphorylated protein (1Y57) showed 
that 4j performed better with -5.4 kcal/mol binding 
energy as compared to 4c and 4i which displayed -4.5 
and -4.4 kcal/mol binding energy respectively and 
formed only a single hydrogen acceptor bond· with 
Asp404. It is to be noted here that the compound 4j 
displayed a similar good docking score of -6.5 
kcal/mol with the phosphorylated protein (2H8H) as 
well. All the synthesized compounds were docked 
into the ATP binding site which is located at a cleft 
between the N and C-terminal lobes, flanked by the 
hinge region, P-loop, helix a C and the activation 
loop. The docked orientations of the 4j compound 
with respect to the native ligands imatinib derivative 
in unphosphorylated protein (1 Y57) and anilino 
-4.4 Lys295 -4.6 
-5.4 Asn391 -6.5 
Lys295 
Ala390 
-6.10 Ser345 
Lys295 
-4.18 Ala390 
-8.3 
-7.6 
quinazoline derivative with phosphorylated protein 
(2H8H) in the pocket site are depicted in Figures 2a 
and 2b respectively. It is to be noted that the isopropyl 
aniline and methyl groups of compound 4j and 4p 
respectively fit in the pocket regions, whereas the 
isopropyl aniline group of compound 4m was 
observed to protrude out of the pocket region thereby 
leading to a lower binding efficiency. In the docked 
conformation of 4p, the methyl group did not fit well 
into the active site cavity. These observations indicate 
that the para.orientation of the isopropyl group in the 
aniline ring in compound 4j may have an important 
role in anchoring it within the active site of the 
receptor. 
Molecular dynamics study 
Molecular dynamics studies were performed for 
further probing the dynamicity and fluctuations of 
ligand at the atomic level in the active sites of the 
unphosphorylated protein ( 1Y57) and phosphorylated 
protein (2H8H) hereafter referred to as T 1 and T2 
respectively. Figure 3a shows the RMSD trajectories 
of T 1 and T2. In the case of Tl, the early peak in 
RMSD of compound 4j during the initial time scale of 
simulation indicates the relaxation of the compound. 
It reached equilibration after 3ns, reflecting its 
stability in the pocket region. The RMSD trajectory 
for T2 was stable with a rise at 3ns, but is observed to 
be relaxing back at 13ns. In order to study the 
behaviour of the compound in a dynamic environment, 
the root mean square fluctuation (RMSF) of protein~ 
compound complex was performed. The RMSF 
trajectory (Figure 3b) was more stable in case of T2 
as compared to Tl; this can be attributed to the open 
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(a) 
(b) 
Fig. 2 - (a) Surface view of Compound 4j (pink) and native 
ligand (green) in the binding pocket of receptor 1Y57 
(Unphosphorylated protein) 
(b) Surface view of Compound 4j (pink) and native ligand (green) 
in the binding pocket of receptor 2H8H (Phosphorylated protein) 
u..----...--------------------------~--~ 
01 
(a) 
10 
1'iatt•• 
conformation of T 1 causing high fluctuations in the 
loop regions. The H-bond distances were calculated 
between compound and amino acid residues involved 
in intermolecular interactions and molecular dynamics 
simulations. The amino group of Lys295 and oxygen 
atom of compound 4j moved apart for Tl, whereas 
quinoline group of Ala390 and isopropyl aniline 
group of the compound 4j separated in T2 during the 
course of the simulation, thereby disrupting the 
hydrogen bond which was formed during docking. 
Rhythmic fluctuation of compound, the amino group 
of Lys295 and oxygen group of Ala390 led to 
increase in distance, causing dissociation of the 
hydrogen bond formed during docking. In compound 
4p, the amino group of Ala390 and oxygen atom of 
Ser345 moved apart for T2 during the course of the 
simulation, thereby disrupting the hydrogen bond 
which was formed during docking. The results 
revealed that compound 4p moved apart from its 
interacting residues similar to compound 4j. The H-
bond distance between the compound 4p and 
interacting residue were ve:ry high as compared to 4j, 
indicating loss of bonding interactions in the active 
site region. A hydrogen bond distance profile was 
calculated between binding pocket residues and 
compound 4j in the entire MD simulation. The 
heteroatoms of the compound formed strong level via 
electrostatic bonds (1 - 2.5 A) between Leu273, the 
atomic molecular dynamics simulations. Some 
interesting observations were noted while comparing 
the simulation results between T 1 and T2. In the case 
of T2, the HB 1 atom of compound 4j and H22 atom 
of Ala293. which were at a distance of 2.6 A initially 
moved apart to a distance of 8.3 A during simulations. 
(b) 
-2H8H PfOt•in fr2J 
- 1YS7 ~in{T1J 
Fig. 3 - (a) Root Mean Square Deviation of compound trajectory for 2H8H (T2) and 1Y57 (Tl) protein. The RMSD value indicates 
stability of compound molecules in the pocket region. (b) .Root Mean Square Fluctuation (RMSF) of protein· compound complex for 
2H8H (T2) and 1 Y57 (Tl) protein 
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Table 2-Statistical results obtained for known Src kinase inhibitors using SVR model (R2= 0.914) 
SVR analysis 
Dataset cc MAPE RMSE 
Total 0.956655 0.176301 4.087586 
Training set 0.945926 0.238429 4.333623 
Test set 0.983458 0.06091 4.450468 
Validation set 0.999823 0.002656 0.001257 
Table 3 - Statistical results obtained for 17 compounds using SVR model (R2= 0.835) 
SVR analysis 
Data set cc 
Total 0.835001 
Training set 0.956363 
Test set 0.756247 
Validation set 0.833723 
Active site analysis 
Dynamics studies revealed that Leu273, Gly274 
and Val281 from Glycine rich and P-loop region; 
Lys393 from Activation loop and Ala293 from (33 of 
the N-terminal lobe may help in understanding the 
residues playing crucial role in ligand binding. 
Targeting the N-terminal lobe .can inhibit the 
regulatory mechanism in Src kinases. Inhibiting 
Leu393 present in the regulatory activation loop, may 
inactivate tyrosine phosphorylation in Src and other 
kinases. The inhibition studies varies between 
phosphorylated and unphosphorylated proteins due to 
certain conformational changes in the active site 
which render (i) displacement of the C helix, which 
removes the catalytically important residue from the 
active site cleft, (ii) change in the activation loop 
adopting an a-helical conformation, which precludes 
binding of peptide substrates and also sequesters 
Tyrosine residue, making it inaccessible for 
phosphorylation, and (iii) constrain in the orientation 
of the N and C lobes which may not be optimal for 
catalysis. Thus carrying out a molecular modelling 
studies against phosphorylated and unphosphorylated 
cSrc kinase protein using synthesized chromone 
derivatives will help us to develop a better cSrc kinase 
inhibitor. 
Structure activity correlation model 
We extracted ICso data from literature for the 
reported Src kinase inhibitors and computed 2D 
molecular descriptors and principal components 
(Table 2)23• The 2D PCA plot displays the chemical 
space occupied by the newly synthesized compounds 
with respect to the known Src inhibitor space. A CC 
MAPE RMSE 
0.36019 50.99193 
0.371753 4.141958 
0.451966 84.40276 
0.557296 95.83819 
of 0.835 was obtained when the 17 synthesiz.ed 
compounds were applied to the model (Table 3). The 
IC5o of compound 4j predicted was similar to the 
value predicted by experimental methods. The clues 
obtained from the structure correlations studies and 
help in fine tuning the presently synthesized 
compounds for further enhancing the bioactivity. 
Cbemoinformatics Analysis 
A drugability check was performed for all the 
17 synthesized compounds. Lipinski rule of 
5 predictions were performed using the Screening 
Assistant 2 tool24• The notion that these compounds 
could be further developed as anti-cancer compounds 
was further assisted by ADME properties predicted 
using PreADMET software25• The selected compound 
4j prioritized in this study fulfilled the above criteria 
indicating that it may be further developed in an oral 
dosage form. TPSA (Topological polar surface area) 
results indicated satisfactory values for all the 
17 compounds26• Thus most synthesiz.ed compounds 
predicted favorable ADME predictions. LAZAR 
(Lazy structure activity relationships) software detects 
carcinogenic properties based on the similarities in 
functional group with carcinogenic compounds 
present in the Lazar database27• 
Conclusion 
In summary, a series of chromone/azachromone 
fused a-aminophosphonate conjugates have been 
synthesized using silica chloride as a new catalyst. All 
the synthesized compounds were evaluated for their c-
Src kinase inhibitory activity and one of the 
compounds 4j was found to be effective with an IC5o 
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value of 15.8 µM. The stability and convergence of 
dynamics results for the phosphorylated and 
unphosphorylated proteins with 4j compound in the 
simulations establishes its potential as an efficient 
inhibitor. Thus docking and dynamics studies 
revealed the compound to be more effective against 
the phophorylated form of Src kinase. Results also 
showed that Leu273, Gly274 and Val281 from 
Glycine rich and P-loop region; Lys393 from 
Activation loop and Ala293 from ~3 of the N-tenninal 
lobe could be considered as potential binding sites for 
cSrc kinase proteins. 
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